Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the study page; no substantive content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:46:13.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The Locations section was expanded with new sites across the US, Canada, Europe, Australia, and other regions, while many of the previous locations were removed.
    Difference
    3%
    Check dated 2025-12-23T22:05:38.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-25T11:27:08.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    - Removal of a general government funding status notice from the page; the study details, eligibility criteria, locations, and contacts remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-18T07:13:05.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Location list updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704' in the Locations section. The site ID remains the same.
    Difference
    0.0%
    Check dated 2025-11-11T02:57:12.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Results for NCT03740165 have been posted, including primary and secondary outcomes, along with updated results posting dates on the study page.
    Difference
    0.1%
    Check dated 2025-11-03T21:17:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.